ACN vs MSTR: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: MSTR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and MSTR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and MSTR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

Strategy Inc, which traded as MicroStrategy until an August 2025 rebrand, began as an enterprise business-intelligence and analytics software vendor and still sells that software (now branded around its AI-powered Strategy One platform). Since 2020 the company has pivoted almost entirely toward accumulating bitcoin as its primary treasury reserve asset, funding purchases through convertible notes, several classes of preferred stock (STRK, STRF, STRD, STRC) and at-the-market common equity sales. As of early July 2026 it held roughly 843,000 to 847,000 BTC at an average cost near $66,000 per coin, making it the largest corporate bitcoin holder in the world.

Full MSTR guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• MSTR drivers: Leveraged bitcoin exposure; Capital-markets machine.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For MSTR, the overwhelming risk is bitcoin price: a large drawdown in BTC would hit both the asset value and the leveraged equity far harder, and the company reported a roughly $14.5 billion non-cash unrealized bitcoin loss in Q1 2026.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; MSTR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and MSTR guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

MSTR. Traditional earnings multiples do not describe Strategy well because quarterly results are dominated by non-cash bitcoin mark-to-market swings, such as the roughly $14.5 billion unrealized loss reported in Q1 2026. Investors instead watch the market value of its bitcoin, the mNAV premium or discount to those coins, and the size of the debt and preferred obligations. In mid-2026 the premium compressed toward or below the value of the underlying bitcoin.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); MSTR shows bitcoin held ~843,000-847,000 BTC, avg btc cost basis ~$66,000 per coin (~$33.1B total), btc holdings value ~$54B, software revenue (quarterly) ~$124M (Q1 2026, +12% YoY).

ACN and MSTR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and MSTR exposure against your real portfolio. It is not an investment adviser.